Market Place
Sourcing Support
Aristea shutters, ending hopes of a Pfizer buyout
11 Feb 2023 //
ENDPTS
Aristea Appoints EMD and Scientists as Clinical Programs Progress
02 Nov 2022 //
PRNEWSWIRE
Aristea Appoints Executive Medical Director and Two Clinical Scientists
02 Nov 2022 //
BIOSPACE
Aristea begins patient dosing in phase 2a trial of RIST4721 in hidradenitis
01 Sep 2022 //
PHARMABIZ
Aristea Announces Dosing of First Patient in Phase 2a Trial of RIST4721
30 Aug 2022 //
PRNEWSWIRE
Aristea Therapeutics Strengthens its Board of Directors
24 Aug 2022 //
PRNEWSWIRE
Aristea Begins Dosing in Open-Label Extension for PIIb Trial of RIST4721
30 Jun 2022 //
PRNEWSWIRE
Aristea Therapeutics Begins Dosing in Phase 2b Trial of RIST4721
28 Mar 2022 //
PRNEWSWIRE
Aristea is Rehoming Proven Molecules for Rare Inflammatory Diseases
24 Jan 2022 //
BIOSPACE
Arena taps Aristea in $70M deal, snags buyout option
29 Jul 2021 //
FIERCEBIOTECH
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.